Abiopharma

🔍 GAROFALO ELIZABETH A. (Executive)

Company: ACADIA PHARMACEUTICALS INC (ACAD)

Report Date: 2025-09-02

Detailed Transactions and Holdings:

• Sold 1,600 shares of Common Stock at $25.9753 per share (Direct)
  Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 25,382.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.97 to $25.991, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.